» Articles » PMID: 30186500

Tetrandrine Alleviates Symptoms of Rheumatoid Arthritis in Rats by Regulating the Expression of Cyclooxygenase-2 and Inflammatory Factors

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2018 Sep 7
PMID 30186500
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The present study aimed to construct a rat model of rheumatoid arthritis (RA) to evaluate changes in pathology, the expression of inflammatory factors and regulation of signaling pathways. The protective effect of tetrandrine (Tet) on tissue lesions induced by RA was also investigated. A total of 60 Wistar rats (100-200 g) were randomly divided into six groups (n=10 per group), namely a blank (NC) group, model group, methotrexate (MTX) group (3 mg/kg body weight), high-dose Tet group (31.25 mg/kg body weight), medium-dose Tet group (18.75 mg/kg body weight) and low-dose Tet group (6.25 mg/kg body weight). A rat model of RA was induced via injection of 0.1 ml complete Freund's adjuvant into the right rear toe. Toe swelling rate, arthritis index and immune organ index were calculated. In addition, cyclooxygenase (COX)-2 expression at the mRNA and protein level in the peripheral blood mononuclear cells (PBMCs) of rats were determined by reverse transcription-quantitative polymerase chain reaction and western blot analysis, respectively. Serum concentrations of inflammatory factors were measured using enzyme-linked immunosorbent assays. It was observed that treatment with Tet alleviated the severity of rear toe swelling associated with RA in rats. Furthermore, Tet exerted anti-inflammatory and immunosuppressive effects in the rat model of RA. Tet also reduced the expression of COX-2 in PBMCs and lowered the concentrations of inflammatory factors in the serum of RA rats. The present data indicate that Tet may exert pharmacological effects in the treatment of RA. The mechanism of action of Tet may be associated with the regulation of inflammatory factors and the inhibition of immune organs.

Citing Articles

Insights on exploring the therapeutic potential and structural modification of Tetrandrine.

Gong L, Liu H, Xu B, Yu T, Wang Y, Niu S Future Med Chem. 2024; 16(24):2687-2700.

PMID: 39606807 PMC: 11731063. DOI: 10.1080/17568919.2024.2432297.


Tetrandrine ameliorated atherosclerosis in vitamin D3/high cholesterol diet-challenged rats via modulation of miR-34a and Wnt5a/Ror2/ABCA1/NF-kB trajectory.

El Zouka Y, Sheta E, Abdelrazek Salama M, Selima E, Refaat R, Salaheldin Abdelhamid Ibrahim S Sci Rep. 2024; 14(1):21371.

PMID: 39266573 PMC: 11393063. DOI: 10.1038/s41598-024-70872-y.


-Chalcone (1-3-diphenyl-2-propen-1-one) as a Therapeutic Candidate in Joint Inflammation via Reduction of TNF-α, IL-1β, IL-6, and IL-17 in Rodents: An Study by RT-PCR and ELISA analysis.

Jabbar Z, Irfan H, Alamgeer , Ullah A, Mahmoud M, Batiha G ACS Omega. 2024; 9(20):22123-22135.

PMID: 38799342 PMC: 11112584. DOI: 10.1021/acsomega.4c00368.


Sequentially Released Liposomes Enhance Anti-Liver Cancer Efficacy of Tetrandrine and Celastrol-Loaded Coix Seed Oil.

Chen Y, Zhang Z, Qian Z, Ma R, Luan M, Sun Y Int J Nanomedicine. 2024; 19:727-742.

PMID: 38288265 PMC: 10822770. DOI: 10.2147/IJN.S446895.


Mechanism underlying the action of Duanteng-Yimu Tang in regulating Treg/Th17 imbalance and anti-rheumatoid arthritis.

Feng W, Wan X, Fan S, Liu C, Zheng X, Liu Q Heliyon. 2023; 9(5):e15867.

PMID: 37206012 PMC: 10189174. DOI: 10.1016/j.heliyon.2023.e15867.


References
1.
Steiniger B, van der Meide P . High-dose interferon-gamma alters the distribution of B lymphocytes and macrophages in rat spleen and lymph nodes. Immunology. 1993; 78(3):461-7. PMC: 1421846. View

2.
Yorifuji M, Sawaji Y, Endo K, Kosaka T, Yamamoto K . Limited efficacy of COX-2 inhibitors on nerve growth factor and metalloproteinases expressions in human synovial fibroblasts. J Orthop Sci. 2016; 21(3):381-8. DOI: 10.1016/j.jos.2016.01.004. View

3.
Xie Q, Tang H, Chen J, Bian R . Pharmacological actions of tetrandrine in inflammatory pulmonary diseases. Acta Pharmacol Sin. 2002; 23(12):1107-13. View

4.
Lai J . Immunomodulatory effects and mechanisms of plant alkaloid tetrandrine in autoimmune diseases. Acta Pharmacol Sin. 2002; 23(12):1093-101. View

5.
Xu X, Gan Y, Xu G, Chen T, Zhou H, Tang J . Tetrandrine citrate eliminates imatinib-resistant chronic myeloid leukemia cells in vitro and in vivo by inhibiting Bcr-Abl/β-catenin axis. J Zhejiang Univ Sci B. 2012; 13(11):867-74. PMC: 3494025. DOI: 10.1631/jzus.B1200021. View